Origin House Files Management Information Circular in Connection with Special Meeting to Consider Proposed Arrangement with Cresco Labs Inc.

 In Cresco, News Release

Ottawa, Canada – May 14, 2019 – CannaRoyalty Corp. d/b/a Origin House (CSE: OH) (OTCQX: ORHOF) (“Origin House or the Company“), a North American cannabis products and brands company, today announced that it has filed its management information circular, letter of transmittal and related proxy materials (collectively, the “Meeting Materials”) and will commence delivery of the Meeting Materials for its special meeting of shareholders (the “Meeting“) to be held on June 11, 2019 in connection with its previously announced statutory plan of arrangement (the “Arrangement”) pursuant to which Cresco Labs Inc. (“Cresco”) will acquire all of the issued and outstanding shares of Origin House.

Shareholders of Origin House should receive these Meeting Materials by mail shortly. The Meeting materials are also available on Origin House’s website at www.originhouse.com and on SEDAR at www.sedar.com, under the Company’s profile.

Origin House encourages shareholders to read the Meeting Materials in detail. To ensure that your Origin House shares will be represented at the Meeting, shareholders should carefully follow the voting instructions provided in the Meeting Materials. The deadline for the receipt of proxies is 10:00 am ET on June 7, 2019.

Assuming that the conditions to the completion of the Arrangement are satisfied (including obtaining the requisite shareholder approval at the Meeting, the receipt of the final order of the Ontario Superior Court of Justice (Commercial List) approving the Arrangement and the satisfaction or waiver of other closing conditions customary in a transaction of this nature), it is expected that the closing of the Arrangement will be completed prior to the end of June 2019.

Recommendation of the Board of Directors

After consulting with its financial and legal advisors, the Board of Directors of Origin House has unanimously recommended that shareholders of Origin House vote FOR the Arrangement.

Shareholder Questions and Assistance

If you have any questions or require assistance voting your shares, please contact our strategic shareholder advisor and proxy solicitation agent, Kingsdale Advisors, at 1-888-302-5677 toll-free in North America, or call collect outside North America at +1-416-867-2272, or by e-mail at contactus@kingsdaleadvisors.com.

About Origin House

Origin House is a growing cannabis brands and distribution company operating across key markets in the U.S. and Canada, with a strategic focus on becoming a preeminent global house of cannabis brands. Origin House’s foundation is in California, the world’s largest regulated cannabis market, where it delivers over 130 branded cannabis products from 50+ brands to the majority of licensed dispensaries. Origin House’s brand development platform is operated out of five licensed facilities located across California, and provides distribution, manufacturing, cultivation and marketing services for its brand partners. Origin House is actively developing infrastructure to support the proliferation of its brands internationally, initially through its acquisition of Canadian retailer 180 Smoke. Origin House’s shares trade on the CSE under the symbol “OH” and on the OTCQX under the symbol “ORHOF”. Origin House is the registered business name of CannaRoyalty Corp. For more information, visit www.originhouse.com.

For further inquiries, please contact:


Jonathan Ross, CFA
LodeRock Advisors Inc.

Priyam Chakraborty
Communications Manager, Origin House

Forward Looking Statements 
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Origin House’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward- looking statements.
Forward-looking statements may include, without limitation, statements relating to the terms of the Arrangement (including the terms, timing, closing and conditions thereof), the timing and receipt of the final order in respect of the Arrangement, the timing and mailing of Meeting Materials, the timing of the Meeting, and the timing, receipt and nature of shareholder, court and regulatory approval for the Arrangement.
Although the Company has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining shareholder, court and regulatory approvals; investing in target companies or projects that are engaged in activities currently considered illegal under US federal law; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward- looking statements in this news release are made as of the date of this release. The Company disclaims any intention or obligation to update or revise such information, except as required by applicable law, and the Company does not assume any liability for disclosure relating to any other company mentioned herein.